BIOEXTRAX AB (85X0) — Financial Flexibility Index
BIOEXTRAX AB (85X0) has a Financial Flexibility Index of 3.65x as of March 2026. Free cash flow of €7.72 Million (operating CF €7.68 Million minus capex €46.00K) represents 4% of total liabilities (€2.11 Million). Explore 85X0 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
BIOEXTRAX AB Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for BIOEXTRAX AB across 5 annual periods. Check 85X0 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Financial Flexibility Index for BIOEXTRAX AB (2021–2025)
Year-by-year free cash flow to debt coverage for BIOEXTRAX AB. For the full cash flow conversion analysis, see cash flow conversion of BIOEXTRAX AB.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -7.37x | €-25.89 Million | €-26.05 Million | €3.51 Million | ▼ -16.6% |
| 2024 | -6.32x | €-18.56 Million | €-18.78 Million | €2.94 Million | ▲ +43.7% |
| 2023 | -11.22x | €-22.21 Million | €-23.31 Million | €1.98 Million | ▼ -537.4% |
| 2022 | -1.76x | €-10.83 Million | €-17.60 Million | €6.15 Million | ▼ -20.7% |
| 2021 | -1.46x | €-7.50 Million | €-8.48 Million | €5.14 Million | — |